Literature DB >> 23073703

Pharmacists as providers of HIV pre-exposure prophylaxis.

Christine Bruno1, Parya Saberi.   

Abstract

The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as their ability to monitor and manage medication adverse effects and drug-drug interactions, clinical pharmacists are well-equipped to play a key role in effective PrEP utilization. Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23073703      PMCID： PMC3501608          DOI： 10.1007/s11096-012-9709-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  25 in total

1.  Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.

Authors:  Sarit A Golub; William Kowalczyk; Corina L Weinberger; Jeffrey T Parsons
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.

Authors:  Virginie Supervie; J Gerardo García-Lerma; Walid Heneine; Sally Blower
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

Review 6.  Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.

Authors:  Andrew M Hall; Bruce M Hendry; Dorothea Nitsch; John O Connolly
Journal:  Am J Kidney Dis       Date:  2011-03-23       Impact factor: 8.860

7.  Preexposure prophylaxis for HIV infection among African women.

Authors:  Lut Van Damme; Amy Corneli; Khatija Ahmed; Kawango Agot; Johan Lombaard; Saidi Kapiga; Mookho Malahleha; Fredrick Owino; Rachel Manongi; Jacob Onyango; Lucky Temu; Modie Constance Monedi; Paul Mak'Oketch; Mankalimeng Makanda; Ilse Reblin; Shumani Elsie Makatu; Lisa Saylor; Haddie Kiernan; Stella Kirkendale; Christina Wong; Robert Grant; Angela Kashuba; Kavita Nanda; Justin Mandala; Katrien Fransen; Jennifer Deese; Tania Crucitti; Timothy D Mastro; Douglas Taylor
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

8.  Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.

Authors:  Timothy B Hallett; Jared M Baeten; Renee Heffron; Ruanne Barnabas; Guy de Bruyn; Íde Cremin; Sinead Delany; Geoffrey P Garnett; Glenda Gray; Leigh Johnson; James McIntyre; Helen Rees; Connie Celum
Journal:  PLoS Med       Date:  2011-11-15       Impact factor: 11.069

Review 9.  Technology-based self-care methods of improving antiretroviral adherence: a systematic review.

Authors:  Parya Saberi; Mallory O Johnson
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

10.  The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.

Authors:  Debby C J Vissers; Hélène A C M Voeten; Nico J D Nagelkerke; J Dik F Habbema; Sake J de Vlas
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240
View more
  14 in total

Review 1.  Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.

Authors:  Kenneth H Mayer; Philip A Chan; Rupa R Patel; Charlene A Flash; Douglas S Krakower
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

2.  Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).

Authors:  B E Meyerson; P C Dinh; J D Agley; B J Hill; D N Motley; G A Carter; W Jayawardene; P T Ryder
Journal:  AIDS Behav       Date:  2019-07

3.  Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.

Authors:  Christina J Sun; Kirsten M Anderson; David Bangsberg; Kim Toevs; Dayna Morrison; Caitlin Wells; Pete Clark; Christina Nicolaidis
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

4.  Accessing Pre-exposure Prophylaxis (PrEP): Perceptions of Current and Potential PrEP Users in Birmingham, Alabama.

Authors:  Whitney S Rice; Kristi L Stringer; Maira Sohail; Kaylee B Crockett; Ghislaine C Atkins; Kachina Kudroff; D Scott Batey; Joshua Hicks; Janet M Turan; Michael J Mugavero; Bulent Turan
Journal:  AIDS Behav       Date:  2019-11

5.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

6.  Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.

Authors:  Sarahmona M Przybyla; Kathleen Parks; Jacob Bleasdale; Joshua Sawyer; Diane Morse
Journal:  Curr Pharm Teach Learn       Date:  2019-02-23

Review 7.  Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic.

Authors:  Iryna B Zablotska; Catherine C O'Connor
Journal:  Curr HIV/AIDS Rep       Date:  2017-12       Impact factor: 5.071

8.  PrEP Continuation, HIV and STI Testing Rates, and Delivery of Preventive Care in a Clinic-Based Cohort.

Authors:  Matthew A Hevey; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Educ Prev       Date:  2018-10

9.  Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

Authors:  Samuel R Bunting; Sarah S Garber; Robert H Goldstein; Timothy D Ritchie; Tamzin J Batteson; Timothy J Keyes
Journal:  J Gen Intern Med       Date:  2020-02-20       Impact factor: 5.128

Review 10.  Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.

Authors:  James Wilton; Heather Senn; Malika Sharma; Darrell Hs Tan
Journal:  HIV AIDS (Auckl)       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.